Provider Profile:
Jay Yang, M.D.

• Leukemia
• Lymphoma
• Myelodysplasia (MDS)

School

• University of Michigan Medical School

Residency

• Providence Hospital and Medical Centers, Internal Medicine

Fellowships

• Providence Hospital and Medical Centers, Hematology Oncology

Awards

• 2019 Detroit's Top Doctors, Hour Magazine
• 2010-2011 Chief Fellow, Department of Internal Medicine, Section of Hematology and Oncology, Providence Hospital and Medical Centers
• 2010 First Place, Oral Presentation Category, Inhibition of AKT and VEGF Signaling Pathways by Targeting both VEGF-R and ErbB-2 in Breast Cancer Cell Lines.
• 2008 Resident of the Year, Department of Internal Medicine, Providence Hospital and Medical Centers (2008)
• 2006 First Place, Oral Presentation Category, Scientific Meeting of the American College of Physicians, Michigan Chapter, Traverse City, MI, Evaluation of Anemia in an Academic Internal Medicine Clinic.
• 2005 First Year Resident of the Year, Department of Internal Medicine, Providence Hospital and Medical Centers

Professional Memberships

• American Society of Clinical Oncology
• American Society of Hematology
• Southwest Oncology Group (SWOG)

• Steensma DP, Wermke M, Klimek VM, Greenberg PL, Font P, Komrokji RS, Yang J, Brunner AM, Carraway HE, et al. Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. Leukemia. 2021 Jun 25
• Li X, Su Y, Hege K, Madlambayan G, Edwards H, Knight T, Polin L, Kushner J, Dzinic SH, White K, Yang J, Miller R, Wang G, Zhao L, Wang Y, Lin H, Taub JW, Ge Y. The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia. Haematologica. 2021
• Alrajjal A, Choudhury M, Yang J, Gabali A. Cell-blocks and hematolymphoid lesions. Cytojournal. 2021;18:7
• Carter JL, Hege K, Yang J, Kalpage HA, Su Y, Edwards H, Hüttemann M, Taub JW, Ge Y. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduction and Targeted Therapy. 2020 Dec 18;5(1):288
• Badar T, Szabo A, Advani A, Wadleigh M, Arslan S, Khan MA, Aldoss I, Siebenaller C, Schultz E, Hefazi M, Shallis RM, Yurkiewicz I, Podoltsev N, Patel AA, Curran E, Balasubramanian S, Yang J, Mattison RJ, et al. Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab. Blood Advances. 2020 May 26;4(10):2308-2316